BioSpace News Archive

Despite the current opioid epidemic that has riveted public attention on addiction, as little as 10 percent of the nearly 20 million people in the United States struggling with drugs and alcohol receive treatment

AMN Healthcare has again been recognized by The Joint Commission for its commitment to placement of high-quality clinicians throughout the healthcare industry.

Somapacitan, a novel growth hormone derivative in development for once-weekly administration of growth hormone, matched the therapeutic benefits of once-daily Norditropin® (somatropin) in a phase 2 trial in children with growth hormone deficiency.

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against AbbVie Inc. and certain of its officers, on behalf of shareholders who purchased or otherwise acquired AbbVie securities between October 25, 2013 and September 18, 2018, both dates inclusive

Wireless storage and security for critical medications, with automated logging of transactions and inventory reporting on-demand

World leader in breast cancer screening celebrates start of Breast Cancer Awareness Month, releases new survey results on breast density

TherapeuticsMD, Inc. today announced that the Company has entered into discussions with the U.S. Food and Drug Administration (FDA) regarding the proposed label for TX-001HR, the Company’s investigational bio-identical hormone therapy combination of estradiol and progesterone in a single, oral softgel for the treatment of moderate-to-severe vasomotor symptoms due to menopause.

Earlier this week, U.S. Senate and House leaders agreed upon an amended opioid legislation package, the SUPPORT for Patients and Communities Act, H.R.6. While OCHIN supports this desperately needed legislation, we are deeply disappointed that a critical piece was omitted, The Overdose Prevention and Patient Safety (OPPS) Act, H.R. 6082.

Bill reforms tax rules that currently penalize investment in job creation, innovation

Steve Greenbaum, CEO of ComForCare, a premier provider of home care, has been appointed to the Board of Directors of the Home Care Association of America (HCAOA).